enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Amisulpride - Wikipedia

    en.wikipedia.org/wiki/Amisulpride

    Amisulpride is approved and used at low doses in the treatment of dysthymia and major depressive disorder. [10] [20] [11] [21] [22] [23] Whereas typical doses used in schizophrenia block postsynaptic dopamine D 2-like receptors and reduce dopaminergic neurotransmission, low doses of amisulpride preferentially block presynaptic dopamine D 2 and D 3 autoreceptors and thereby disinhibit dopamine ...

  3. Rebound effect - Wikipedia

    en.wikipedia.org/wiki/Rebound_effect

    The rebound effect, or pharmaceutical rebound phenomenon, is the emergence or re-emergence of symptoms that were either absent or controlled while taking a medication, but appear when that same medication is discontinued, or reduced in dosage.

  4. Sulbutiamine - Wikipedia

    en.wikipedia.org/wiki/Sulbutiamine

    Adverse effects found in clinical trials are usually limited to headache and gastrointestinal discomfort when high doses are used. While daily use can result in tolerance and paradoxical drowsiness, increasing the dose is strongly discouraged and side effects can include diarrhea, bladder infections, bronchitis, back pain, abdominal pain, insomnia, constipation, gastroenteritis, headache ...

  5. Etifoxine - Wikipedia

    en.wikipedia.org/wiki/Etifoxine

    The usual dosage of etifoxine (as the hydrochloride salt) is 150 to 200 mg per day in divided doses of 50 to 100 mg two to three times per day (e.g., 50 mg–50 mg–100 mg). [ 2 ] [ 7 ] [ 6 ] [ 18 ] [ 1 ] [ 19 ] [ 20 ] It is taken for a few days to a few weeks, but no longer than 12 weeks.

  6. Side effects of bicalutamide - Wikipedia

    en.wikipedia.org/wiki/Side_effects_of_bicalutamide

    These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...

  7. Amineptine - Wikipedia

    en.wikipedia.org/wiki/Amineptine

    After a single 200 mg oral dose of amineptine, mean peak plasma levels of amineptine were around 750 to 940 ng/mL (2,216–2,777 nM), while those of its major metabolite were about 750 to 970 ng/mL (2,216–3,135 nM). [3] The time to peak concentrations is about 1 hour for amineptine and 1.5 hours for its major metabolite.

  8. Has rebounding become a strength and important part of ... - AOL

    www.aol.com/rebounding-become-strength-important...

    The Miami Heat’s improved rebounding has become an important part of its winning formula this season. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...

  9. Sulpiride - Wikipedia

    en.wikipedia.org/wiki/Sulpiride

    Sulpiride, sold under the brand name Dogmatil among others, is an atypical antipsychotic (although some texts have referred to it as a typical antipsychotic) [10] medication of the benzamide class which is used mainly in the treatment of psychosis associated with schizophrenia and major depressive disorder, and is sometimes used in low dosage to treat anxiety and mild depression.